+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pharmaceutical Corporate Reputation"

The Corporate Reputation of Pharma in 2022 - The Patient Perspective - USA Edition - The Views of 361 USA Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2022 - The Patient Perspective - USA Edition - The Views of 361 USA Patient Groups

  • Report
  • May 2023
  • 50 Pages
  • United States
The Corporate Reputation of Pharma in 2022 - The Patient Perspective - Global Edition - Product Thumbnail Image

The Corporate Reputation of Pharma in 2022 - The Patient Perspective - Global Edition

  • Report
  • April 2023
  • 138 Pages
  • Global
The Corporate Reputation of Pharma in 2022 - The Patient Perspective - Neurology Edition: The Views of 258 Neurology Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2022 - The Patient Perspective - Neurology Edition: The Views of 258 Neurology Patient Groups

  • Report
  • November 2022
  • 54 Pages
  • Global
The Corporate Reputation of Pharma in 2021- The Patient Perspective - Autoimmune Edition - The Views of 293 Patient Groups (138 of these respondent patient groups specialised in arthritis) - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021- The Patient Perspective - Autoimmune Edition - The Views of 293 Patient Groups (138 of these respondent patient groups specialised in arthritis)

  • Report
  • November 2022
  • 57 Pages
  • Global
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Respiratory Edition - The Views of 121 Respiratory Conditions Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Respiratory Edition - The Views of 121 Respiratory Conditions Patient Groups

  • Report
  • October 2022
  • 58 Pages
  • Global
The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups

  • Report
  • October 2022
  • 58 Pages
  • Global
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Spain Edition: The Views of 154 Spanish Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Spain Edition: The Views of 154 Spanish Patient Groups

  • Report
  • September 2022
  • 559 Pages
  • Spain
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Italy Edition: The Views of 103 Italian Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Italy Edition: The Views of 103 Italian Patient Groups

  • Report
  • September 2022
  • 59 Pages
  • Italy
The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German Patient Groups

  • Report
  • August 2022
  • 59 Pages
  • Germany
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Asia Edition - The Views of 300 Asian Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Asia Edition - The Views of 300 Asian Patient Groups

  • Report
  • August 2022
  • 58 Pages
  • Asia Pacific
The Corporate Reputation of Pharma in 2021- The Patient Perspective - France Edition - The Views of 109 French Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021- The Patient Perspective - France Edition - The Views of 109 French Patient Groups

  • Report
  • July 2022
  • 60 Pages
  • France
The Corporate Reputation of Pharma in 2021- The Patient Perspective - UK Edition - The Views of 111 UK Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021- The Patient Perspective - UK Edition - The Views of 111 UK Patient Groups

  • Report
  • July 2022
  • 59 Pages
  • United Kingdom
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - HIV/AIDS Edition -The Views of 168 HIV/AIDS Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - HIV/AIDS Edition -The Views of 168 HIV/AIDS Patient Groups

  • Report
  • June 2022
  • 91 Pages
  • Global
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Canada Edition - The Views of 124 Canadian Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Canada Edition - The Views of 124 Canadian Patient Groups

  • Report
  • June 2022
  • 50 Pages
  • Canada
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Cancer Edition - The Views of 520 Cancer Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Cancer Edition - The Views of 520 Cancer Patient Groups

  • Report
  • May 2022
  • 64 Pages
  • Global
The Corporate Reputation of Pharma in 2020 - The Patient Perspective - Mental Health Edition: The Views of 80 Mental Health Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2020 - The Patient Perspective - Mental Health Edition: The Views of 80 Mental Health Patient Groups

  • Report
  • November 2021
  • 49 Pages
  • Global
  • 16 Results (Page 1 of 1)
Loading Indicator

The Pharmaceutical Corporate Reputation market is a subset of the Healthcare Services industry. It focuses on the reputation of pharmaceutical companies, which is determined by public opinion, media coverage, and other factors. Companies in this market strive to build and maintain a positive reputation in order to attract customers, investors, and partners. They use a variety of strategies, such as public relations, marketing, and corporate social responsibility initiatives, to build trust and loyalty. Some of the major players in the Pharmaceutical Corporate Reputation market include Pfizer, Merck, Johnson & Johnson, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, and Bayer. Show Less Read more